{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:00:58Z","timestamp":1791234058652,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"crossref","award":["FKZ: ZMI1-2520DAT02C"],"award-info":[{"award-number":["FKZ: ZMI1-2520DAT02C"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002957","name":"Technische Universit\u00e4t Dresden","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002957","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Given the geographical sparsity of Rare Diseases (RDs), assembling a cohort is often a challenging task. Common data models (CDM) can harmonize disparate sources of data that can be the basis of decision support systems and artificial intelligence-based studies, leading to new insights in the field. This work is sought to support the design of large-scale multi-center studies for rare diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In an interdisciplinary group, we derived a list of elements of RDs in three medical domains (endocrinology, gastroenterology, and pneumonology) according to specialist knowledge and clinical guidelines in an iterative process. We then defined a RDs data structure that matched all our data elements and built Extract, Transform, Load (ETL) processes to transfer the structure to a joint CDM. To ensure interoperability of our developed CDM and its subsequent usage for further RDs domains, we ultimately mapped it to Observational Medical Outcomes Partnership (OMOP) CDM. We then included a fourth domain, hematology, as a proof-of-concept and mapped an acute myeloid leukemia (AML) dataset to the developed CDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have developed an OMOP-based rare diseases common data model (RD-CDM) using data elements from the three domains (endocrinology, gastroenterology, and pneumonology) and tested the CDM using data from the hematology domain. The total study cohort included 61,697 patients. After aligning our modules with those of Medical Informatics Initiative (MII) Core Dataset (CDS) modules, we leveraged its ETL process. This facilitated the seamless transfer of demographic information, diagnoses, procedures, laboratory results, and medication modules from our RD-CDM to the OMOP. For the phenotypes and genotypes, we developed a second ETL process. We finally derived lessons learned for customizing our RD-CDM for different RDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This work can serve as a blueprint for other domains as its modularized structure could be extended towards novel data types. An interdisciplinary group of stakeholders that are actively supporting the project's progress is necessary to reach a comprehensive CDM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The customized data structure related to\u00a0our RD-CDM can be used to perform multi-center studies to test data-driven hypotheses on a larger scale and take advantage of the analytical tools offered by the OHDSI community.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-024-03312-9","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:02:16Z","timestamp":1723644136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5109","authenticated-orcid":false,"given":"Najia","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Guengoeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Facchinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Mondorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Stratmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khader","family":"Musleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Tchertov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Gebler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannik","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena S.","family":"Frischen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Nasirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Srisuwananukorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6llig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Niklas","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Moritz","family":"Middeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Wolfien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Sedlmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,14]]},"reference":[{"key":"3312_CR1","unstructured":"Commissioner O of the. FDA. FDA; 2022 [cited 2023 Nov 27]. Rare Diseases at FDA. Available from: https:\/\/www.fda.gov\/patients\/rare-diseases-fda"},{"key":"3312_CR2","first-page":"28","volume":"16","author":"S Wakap","year":"2019","unstructured":"Wakap S, Lambert D, Olry A, Rodwell C, Gueydan C, Val\u00e9rie L, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2019;16:28.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"3312_CR3","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00103-007-0381-9","volume":"50","author":"S Aym\u00e9","year":"2007","unstructured":"Aym\u00e9 S, Schmidtke J. Networking for rare diseases: a necessity for Europe. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(12):1477\u201383.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"12","key":"3312_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/jmedgenet-2019-106111","volume":"56","author":"D Bick","year":"2019","unstructured":"Bick D, Jones M, Taylor SL, Taft RJ, Belmont J. Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. J Med Genet. 2019;56(12):783\u201391.","journal-title":"J Med Genet"},{"issue":"5","key":"3312_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrg.2017.116","volume":"19","author":"CF Wright","year":"2018","unstructured":"Wright CF, FitzPatrick DR, Firth HV. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19(5):253\u201368.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"3312_CR6","first-page":"11","volume":"64","author":"SY Chu","year":"2017","unstructured":"Chu SY, Weng CY. Introduction to genetic\/rare disease and the application of genetic counseling. Hu Li Za Zhi. 2017;64(5):11\u20137.","journal-title":"Hu Li Za Zhi"},{"issue":"6","key":"3312_CR7","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.chest.2017.12.018","volume":"153","author":"JK Stoller","year":"2018","unstructured":"Stoller JK. The challenge of rare diseases. Chest. 2018;153(6):1309\u201314.","journal-title":"Chest"},{"issue":"2","key":"3312_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","volume":"19","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, et al. Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov. 2020;19(2):93\u2013111.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3312_CR9","doi-asserted-by":"publisher","first-page":"e201965","DOI":"10.1001\/jamanetworkopen.2020.1965","volume":"3","author":"AA Mitani","year":"2020","unstructured":"Mitani AA, Haneuse S. Small data challenges of studying rare diseases. JAMA Netw Open. 2020;3(3):e201965. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.1965.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3312_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/genes14010196","volume":"14","author":"L Shu","year":"2023","unstructured":"Shu L, Maroilley T, Tarailo-Graovac M. The Power of Clinical Diagnosis for Deciphering Complex Genetic Mechanisms in Rare Diseases. Genes. 2023;14(1):196.","journal-title":"Genes"},{"key":"3312_CR11","unstructured":"Personalised medicine [Internet]. 2023 [cited 2023 Nov 27]. Available from: https:\/\/research-and-innovation.ec.europa.eu\/research-area\/health\/personalised-medicine_en"},{"issue":"3","key":"3312_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.18","volume":"15","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD, Dumontier M, Aalbersberg IJJ, Appleton G, Axton M, Baak A, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;15(3): 160018.","journal-title":"Sci Data"},{"issue":"1","key":"3312_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13023-022-02558-5","volume":"17","author":"VB dos Santos","year":"2022","unstructured":"dos Santos VB, Bernab\u00e9 CH, Zhang S, Abaza H, Benis N, C\u00e1mara A, et al. Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries. Orphanet J Rare Dis. 2022;17(1):436. https:\/\/doi.org\/10.1186\/s13023-022-02558-5.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3312_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","volume":"18","author":"IC Hageman","year":"2023","unstructured":"Hageman IC, van Rooij IALM, de Blaauw I, Trajanovska M, King SK. A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance. Orphanet J Rare Dis. 2023;18(1):106. https:\/\/doi.org\/10.1186\/s13023-023-02719-0.","journal-title":"Orphanet J Rare Dis"},{"key":"3312_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12911-023-02115-5","volume":"23","author":"A Torab-Miandoab","year":"2023","unstructured":"Torab-Miandoab A, Samad-Soltani T, Jodati A, Rezaei-Hachesu P. Interoperability of heterogeneous health information systems: a systematic literature review. BMC Med Inform Decis Mak. 2023;23:18.","journal-title":"BMC Med Inform Decis Mak"},{"key":"3312_CR16","doi-asserted-by":"crossref","unstructured":"A review of interoperability standards in E-health and imperatives for their adoption in Africa. S Afr Comput J. 2013;50. https:\/\/sacj.cs.uct.ac.za\/index.php\/sacj\/article\/view\/176","DOI":"10.18489\/sacj.v50i1.176"},{"issue":"3","key":"3312_CR17","first-page":"2028","volume":"1","author":"I Olaronke","year":"2013","unstructured":"Olaronke I, Soriyan A, Gambo I, Olaleke J. Interoperability in healthcare: benefits, challenges and resolutions. Int J Innov Appl Stud. 2013;1(3):2028\u20139324.","journal-title":"Int J Innov Appl Stud"},{"key":"3312_CR18","unstructured":"Overview\u2014FHIR v5.0.0. [cited 2023 Nov 27]. Available from: https:\/\/www.hl7.org\/fhir\/overview.html"},{"key":"3312_CR19","unstructured":"The Medical Informatics Initiative\u2019s core data set | Medical Informatics Initiative [Internet]. [cited 2023 Nov 27]. Available from: https:\/\/www.medizininformatik-initiative.de\/en\/medical-informatics-initiatives-core-data-set"},{"issue":"1","key":"3312_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13326-022-00264-6","volume":"13","author":"R Kaliyaperumal","year":"2022","unstructured":"Kaliyaperumal R, Wilkinson MD, Moreno PA, Benis N, Cornet R, dos SantosVieira B, et al. Semantic modelling of common data elements for rare disease registries, and a prototype workflow for their deployment over registry data. J Biomed Semant. 2022;13(1):9. https:\/\/doi.org\/10.1186\/s13326-022-00264-6.","journal-title":"J Biomed Semant"},{"key":"3312_CR21","unstructured":"European Platform on Rare Disease Registration. [cited 2023 Nov 27]. Available from: https:\/\/eu-rd-platform.jrc.ec.europa.eu"},{"issue":"1","key":"3312_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/amiajnl-2014-002794","volume":"22","author":"R Choquet","year":"2015","unstructured":"Choquet R, Maaroufi M, de Carrara A, Messiaen C, Luigi E, Landais P. A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research. J Am Med Inf Assoc. 2015;22(1):76\u201385. https:\/\/doi.org\/10.1136\/amiajnl-2014-002794.","journal-title":"J Am Med Inf Assoc"},{"key":"3312_CR23","doi-asserted-by":"publisher","first-page":"e44641","DOI":"10.2196\/44641","volume":"25","author":"FA Bernardi","year":"2023","unstructured":"Bernardi FA, Mello de Oliveira B, Bettiol Yamada D, Artifon M, Schmidt AM, Machado Scheibe V, et al. The minimum data set for rare diseases: systematic review. J Med Internet Res. 2023;25:e44641.","journal-title":"J Med Internet Res"},{"issue":"5","key":"3312_CR24","doi-asserted-by":"publisher","DOI":"10.2196\/32158","volume":"10","author":"H Abaza","year":"2022","unstructured":"Abaza H, Kadioglu D, Martin S, Papadopoulou A, Dos Santos VB, Schaefer F, et al. Domain-specific common data elements for rare disease registration: conceptual approach of a european joint initiative toward semantic interoperability in rare disease research. JMIR Med Inform. 2022;10(5): e32158.","journal-title":"JMIR Med Inform"},{"issue":"1","key":"3312_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/cts.12845","volume":"14","author":"AP Mullin","year":"2021","unstructured":"Mullin AP, Corey D, Turner EC, Liwski R, Olson D, Burton J, et al. Standardized data structures in rare diseases: CDISC user guides for duchenne muscular dystrophy and Huntington\u2019s disease. Clin Transl Sci. 2021;14(1):214\u201321.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"3312_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12911-020-01168-0","volume":"20","author":"HH Kim","year":"2020","unstructured":"Kim HH, Park YR, Lee S, Kim JH. Composite CDE: modeling composite relationships between common data elements for representing complex clinical data. BMC Med Inform Decis Mak. 2020;20(1):147.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"01","key":"3312_CR27","doi-asserted-by":"publisher","first-page":"054","DOI":"10.1055\/s-0037-1617452","volume":"09","author":"C Maier","year":"2018","unstructured":"Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, et al. Towards implementation of OMOP in a German University Hospital Consortium. Appl Clin Inform. 2018;09(01):054\u201361. https:\/\/doi.org\/10.1055\/s-0037-1617452.","journal-title":"Appl Clin Inform"},{"issue":"19","key":"3312_CR28","doi-asserted-by":"publisher","first-page":"11834","DOI":"10.3390\/ijms231911834","volume":"23","author":"N Ahmadi","year":"2022","unstructured":"Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M. OMOP CDM can facilitate data-driven studies for cancer prediction: a systematic review. Int J Mol Sci. 2022;23(19):11834.","journal-title":"Int J Mol Sci"},{"key":"3312_CR29","doi-asserted-by":"crossref","unstructured":"Ahmadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M. Cancer prediction on OMOP CDM\u2014a rapid review. In German Medical Science GMS Publishing House;2022. p. DocAbstr. 23.","DOI":"10.3390\/ijms231911834"},{"key":"3312_CR30","doi-asserted-by":"publisher","unstructured":"Ahmadi N, Zoch M, Sedlmayr B, Schuler K, Hahn W, Sedlmayr M, et al. Context-sensitive common data models for genetic rare diseases\u2014a concept. In: Healthcare transformation with informatics and artificial intelligence. IOS Press; 2023 [cited 2023 Oct 23]. p. 139\u201340. https:\/\/doi.org\/10.3233\/SHTI230443","DOI":"10.3233\/SHTI230443"},{"issue":"1","key":"3312_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12911-018-0646-2","volume":"18","author":"KB Wagholikar","year":"2018","unstructured":"Wagholikar KB, Dessai P, Sanz J, Mendis ME, Bell DS, Murphy SN. Implementation of informatics for integrating biology and the bedside (i2b2) platform as Docker containers. BMC Med Inf Decis Mak. 2018;18(1):66. https:\/\/doi.org\/10.1186\/s12911-018-0646-2.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"1","key":"3312_CR32","doi-asserted-by":"publisher","first-page":"e45948","DOI":"10.2196\/45948","volume":"25","author":"M Wolfien","year":"2023","unstructured":"Wolfien M, Ahmadi N, Fitzer K, Grummt S, Heine KL, Jung IC, et al. Ten topics to get started in medical informatics research. J Med Internet Res. 2023;25(1):e45948.","journal-title":"J Med Internet Res"},{"issue":"281","key":"3312_CR33","first-page":"138","volume":"27","author":"M Zoch","year":"2021","unstructured":"Zoch M, Gierschner C, Peng Y, Gruhl M, Leutner LA, Sedlmayr M, et al. Adaption of the OMOP CDM for rare diseases. Stud Health Technol Inform. 2021;27(281):138\u201342.","journal-title":"Stud Health Technol Inform"},{"key":"3312_CR34","unstructured":"Genomic Data Harmonization through the OMOP Standardized Vocabularies\u2014OHDSI. [cited 2023 Nov 27]. Available from: https:\/\/www.ohdsi.org\/2020-global-symposium-showcase-13\/"},{"issue":"290","key":"3312_CR35","first-page":"56","volume":"6","author":"M Buy","year":"2022","unstructured":"Buy M, Digan W, Chen X, Husson J, M\u00e9nager M, Rieux-Laucat F, et al. A multi-omics common data model for primary immunodeficiencies. Stud Health Technol Inform. 2022;6(290):56\u201360.","journal-title":"Stud Health Technol Inform"},{"issue":"5","key":"3312_CR36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ajhg.2008.09.017","volume":"83","author":"PN Robinson","year":"2008","unstructured":"Robinson PN, K\u00f6hler S, Bauer S, Seelow D, Horn D, Mundlos S. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83(5):610\u20135.","journal-title":"Am J Hum Genet"},{"key":"3312_CR37","unstructured":"BfArM\u2014ORPHAcodes [Internet]. [cited 2023 Aug 7]. Available from: https:\/\/www.bfarm.de\/DE\/Kodiersysteme\/Kooperationen-und-Projekte\/Orphanet\/Orphanet-International\/Orphacodes\/_node.html"},{"issue":"1","key":"3312_CR38","first-page":"1","volume":"2","author":"XA Zhang","year":"2019","unstructured":"Zhang XA, Yates A, Vasilevsky N, Gourdine JP, Callahan TJ, Carmody LC, et al. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery. Digit Med. 2019;2(1):1\u20139.","journal-title":"Digit Med"},{"key":"3312_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104413","volume":"87","author":"JT Reese","year":"2023","unstructured":"Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, et al. Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. 2023;87: 104413.","journal-title":"EBioMedicine"},{"issue":"1","key":"3312_CR40","doi-asserted-by":"publisher","first-page":"e45116","DOI":"10.2196\/45116","volume":"11","author":"N Ahmadi","year":"2023","unstructured":"Ahmadi N, Zoch M, Kelbert P, Noll R, Schaaf J, Wolfien M, et al. Methods used in the development of common data models for health data: scoping review. JMIR Med Inf. 2023;11(1):e45116.","journal-title":"JMIR Med Inf"},{"key":"3312_CR41","unstructured":"SATURN Projekt. [cited 2023 Nov 27]. Available from: https:\/\/www.saturn-projekt.de\/"},{"issue":"1","key":"3312_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1145\/320434.320440","volume":"1","author":"PPS Chen","year":"1976","unstructured":"Chen PPS. The entity-relationship model\u2014toward a unified view of data. ACM Trans Database Syst. 1976;1(1):9\u201336. https:\/\/doi.org\/10.1145\/320434.320440.","journal-title":"ACM Trans Database Syst"},{"key":"3312_CR43","unstructured":"fhir-to-omop. Observational Health Data Sciences and Informatics; 2023 [cited 2023 Nov 27]. Available from: https:\/\/github.com\/OHDSI\/ETL-German-FHIR-Core"},{"key":"3312_CR44","unstructured":"Informatics OHDS and Chapter 13 Patient-Level Prediction | The Book of OHDSI [Internet]. [cited 2023 Nov 27]. Available from: https:\/\/ohdsi.github.io\/TheBookOfOhdsi\/"},{"key":"3312_CR45","unstructured":"HADES. [cited 2023 Aug 4]. Available from: https:\/\/ohdsi.github.io\/Hades\/"},{"key":"3312_CR46","unstructured":"Ahmadi N. NajiaAhmadi\/ETL-genotype-phenotype-to-OMOP: extract transform load (ETL) processes to write gene mutation data and phenotype data to OMOP CDM. [cited 2023 Nov 27]. Available from: https:\/\/github.com\/NajiaAhmadi\/ETL-Genotype-Phenotype-to-OMOP"},{"key":"3312_CR47","unstructured":"Hitachi Vantara Lumada and Pentaho Documentation. 2020 [cited 2023 Nov 27]. Pentaho Data Integration. Available from: https:\/\/help.hitachivantara.com\/Documentation\/Pentaho\/Data_Integration_and_Analytics\/9.1\/Products\/Pentaho_Data_Integration"},{"key":"3312_CR48","unstructured":"VORBEHALTEN IUAR. Orphanet: Suche \/Krankheit. [cited 2023 Nov 27]. Available from: https:\/\/www.orpha.net\/consor\/cgi-bin\/Disease_Search_Simple.php?lng=DE"},{"key":"3312_CR49","unstructured":"Athena. [cited 2023 Nov 27]. Available from: https:\/\/athena.ohdsi.org\/search-terms\/start"},{"key":"3312_CR50","unstructured":"BfArM\u2014OPS. [cited 2023 Nov 27]. Available from: https:\/\/www.bfarm.de\/EN\/Code-systems\/Classifications\/OPS-ICHI\/OPS\/_node.html"},{"key":"3312_CR51","unstructured":"BfArM\u2014LOINC. [cited 2023 Nov 27]. Available from: https:\/\/www.bfarm.de\/EN\/Code-systems\/Terminologies\/LOINC-UCUM\/LOINC-and-RELMA\/_node.html"},{"key":"3312_CR52","unstructured":"RxNorm Overview. U.S. National Library of Medicine; [cited 2023 Nov 27]. https:\/\/www.nlm.nih.gov\/research\/umls\/rxnorm\/overview.html"},{"key":"3312_CR53","unstructured":"Anatomical Therapeutic Chemical (ATC) Classification. [cited 2023 Nov 27]. https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification"},{"key":"3312_CR54","unstructured":"Diagnosis-related group (DRG). [cited 2023 Nov 27]. https:\/\/www.ohdsi.org\/web\/wiki\/doku.php?id=documentation:vocabulary:drg"},{"key":"3312_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/978-3-319-67144-4_22","volume":"1031","author":"S Schee Genannt Halfmann","year":"2017","unstructured":"Schee Genannt Halfmann S, M\u00e4hlmann L, Leyens L, Reumann M, Brand A. Personalized medicine: What\u2019s in it for rare diseases? Adv Exp Med Biol. 2017;1031:387\u2013404.","journal-title":"Adv Exp Med Biol"},{"issue":"5\u20136","key":"3312_CR56","first-page":"287","volume":"17","author":"D Horgan","year":"2014","unstructured":"Horgan D, Jansen M, Leyens L, Lal JA, Sudbrak R, Hackenitz E, et al. An index of barriers for the implementation of personalised medicine and pharmacogenomics in Europe. PHG. 2014;17(5\u20136):287\u201398.","journal-title":"PHG"},{"key":"3312_CR57","doi-asserted-by":"publisher","first-page":"1214766","DOI":"10.3389\/fpubh.2023.1214766","volume":"11","author":"R Raycheva","year":"2023","unstructured":"Raycheva R, Kostadinov K, Mitova E, Bogoeva N, Iskrov G, Stefanov G, et al. Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review. Front Public Health. 2023;11:1214766.","journal-title":"Front Public Health"},{"key":"3312_CR58","unstructured":"Sequence Variant Nomenclature [Internet]. [cited 2023 Nov 27]. Available from: https:\/\/varnomen.hgvs.org\/"},{"issue":"12","key":"3312_CR59","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377. https:\/\/doi.org\/10.1182\/blood.2022016867.","journal-title":"Blood"},{"issue":"8","key":"3312_CR60","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s40273-017-0513-5","volume":"35","author":"CV Asche","year":"2017","unstructured":"Asche CV, Seal B, Kahler KH, Oehrlein EM, Baumgartner MG. Evaluation of healthcare interventions and big data: review of associated data issues. Pharmacoeconomics. 2017;35(8):759\u201365. https:\/\/doi.org\/10.1007\/s40273-017-0513-5.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"3312_CR61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40273-020-00981-9","volume":"39","author":"S Kent","year":"2021","unstructured":"Kent S, Burn E, Dawoud D, Jonsson P, \u00d8stby JT, Hughes N, et al. Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2021;39(3):275\u201385.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"3312_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-024-01076-x","volume":"7","author":"JN Eckardt","year":"2024","unstructured":"Eckardt JN, Hahn W, R\u00f6llig C, Stasik S, Platzbecker U, M\u00fcller-Tidow C, et al. Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence. npj Digit Med. 2024;7(1):1\u201311.","journal-title":"npj Digit Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-024-03312-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-024-03312-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:04:33Z","timestamp":1723644273000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-024-03312-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3312"],"URL":"https:\/\/doi.org\/10.1186\/s13023-024-03312-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3719430\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SATURN Project received approval from the Ethics Committee of the Department of Medicine at Goethe University, located at University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, under reference number 2022-1088, and from the Ethics Committee of Technische Universit\u00e4t Dresden, situated at Fetscherstra\u00dfe 74, 01307 Dresden, under reference number SR-EK-56012023.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}